Boji Medical Technology (300404.SZ) released its semi-annual report for 2024, with revenue of 0.341 billion...
Boji Medical Technology (300404.SZ) released its semi-annual report for 2024, with revenue of 0.341 billion yuan, a year-on-year increase of 46.92%. The net income attributable to the shareholder of the listed company is 30.1351 million yuan, a year-on-year increase of 71.04%. The net income attributable to the shareholder of the listed company, after deducting non-recurring gains and losses, is 25.6604 million yuan, a year-on-year increase of 164.08%. The basic earnings per share is 0.0789 yuan.
During the reporting period, the company's revenue from clinical research services was 0.271 billion yuan, a year-on-year increase of 56.10%. The increase in the amount of clinical research service contracts was 0.719 billion yuan, a year-on-year increase of 60.99%. During the reporting period, the company's revenue from pre-clinical research services was 41.7951 million yuan, a year-on-year increase of 46.18%.